An AI model developed by researchers at New York-Presbyterian and Columbia University Irving Medical Center has received approval from the Food and Drug Administration for use in detecting structural heart disease through electrocardiograms (ECGs), according to a news release. Known as EchoNext, the deep learning model was trained to detect a broad range of structural abnormalities, as published in Nature: The model analyzes a routine 12-lead ECG and estimates whether a patient is likely to …
Read More
